COVID-19 information 6. Endocrine system Guidelines
Diabetes
Management
BNSSG Blood Glucose Management in Type 2 Diabetes
Blood Glucose Monitoring
Clinical Pathway for the use of diabetes technologies in all patients with Type 1 Diabetes
BNSSG Type 1 Blood Glucose Monitoring Guidance (Primary Care)
BNSSG Type 2 Diabetes Blood Glucose Monitoring Guidance (Adults)
Information on Continuous Glucose Monitoring (CGM) in Type 1 Diabetes for Primary Care which includes information on GlucoRx Aidex, Dexcom One, Glucomen Day, Freestyle Libre 2
Insulin
SGLT-2 inhibitors
Advice on the use of SGLT-2 inhibitors in Type 2 Diabetes, Heart Failure and Chronic Kidney Disease
Osteoporosis
When to start Osteoporosis Treatment 2022 minor amendment
Osteoporosis - oral treatment duration, denosumab and drug holiday guidance 2021
BNSSG Osteoporosis Clinic Referral Guidance for GPs 2021
Bisphosphonate Drug Holiday Algorithm June 2021
Denosumab Drug Holiday Algorithm June 2021
Hormone Therapy for Gender Reassignment
Local Guidance
Guidance from Gender Identity Clinics (GIC) Clinics
-
The Laurels Gender Identity Clinic provided by Devon Partnership NHS Trust in Exeter - PG12 Pharmacological Treatment of Gender Dysphoria
-
The Tavistock and Portman NHS foundation Trust (used to be known as Charing Cross gender identity clinic) in London
Menopause
BNSSG Menopause Guidelines and HRT Prescribing Pathway (updated July 2022)
Corticosteroids
Guidance on issuing the Steroid Emergency Card in adults
BNSSG Tool on Implementing the NPSA alert on the Emergency steroid card
For information regarding provision of a Steroid Emergency card for paediatrics, please see Paediatric Chapter 6.2 for further details